Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ALLO - Allogene Therapeutics, Inc.
-955 K
LAST VALUE
39.01%
2 YEAR CAGR
-32.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR